Pseudo-Pemphigoid Gestationis Eruption Following SARS-CoV-2 Vaccination with mRNA Vaccine

被引：1
|
作者：
de Lorenzi, Caroline [1 ]
Kaya, Guerkan [1 ,2 ]
Trellu, Laurence Toutous [1 ]
机构：
[1] Geneva Univ Hosp, Dept Dermatol & Venereol, Rue Gabrielle Perret Gentil 4, CH-1205 Geneva, Switzerland
[2] Geneva Univ Hosp, Dept Clin Pathol, CH-1205 Geneva, Switzerland
来源：
DERMATOPATHOLOGY | 2022年 / 9卷 / 03期
关键词：
pemphigoid gestationis; bullous auto-immune disease; mRNA vaccine; SARS-CoV-2;
D O I：
10.3390/dermatopathology9030025
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Auto-immune reactions, including auto-immune bullous disease, have been reported following SARS-CoV-2 virus vaccination. Few cases of bullous pemphigoid are described, but there has been no case of pemphigoid gestationis. We report the first case here.
引用
收藏
页码：203 / 206
页数：4
相关论文
共 50 条
  • [31] SARS-CoV-2 mRNA vaccine requires signal peptide to induce antibody responses
    Mo, Chuncong
    Li, Xiao
    Wu, Qianying
    Fan, Ye
    Liu, Donglan
    Zhu, Yuhui
    Yang, Yujie
    Liao, Xiaohong
    Zhou, Zhichao
    Zhou, Liling
    Li, Qiuru
    Zhang, Qiong
    Liu, Wenkuan
    Zhou, Rong
    Tian, Xingui
    VACCINE, 2023, 41 (46) : 6863 - 6869
  • [32] Bioinformatics Designing and Molecular Modelling of a Universal mRNA Vaccine for SARS-CoV-2 Infection
    Oladipo, Elijah Kolawole
    Adeniyi, Micheal Oluwafemi
    Ogunlowo, Mercy Temiloluwa
    Irewolede, Boluwatife Ayobami
    Adekanola, Victoria Oluwapelumi
    Oluseyi, Glory Samuel
    Omilola, Janet Abisola
    Udoh, Anietie Femi
    Olufemi, Seun Elijah
    Adediran, Daniel Adewole
    Olonade, Aanuoluwapo
    Idowu, Usman Abiodun
    Kolawole, Olatunji M.
    Oloke, Julius Kola
    Onyeaka, Helen
    VACCINES, 2022, 10 (12)
  • [33] Heterologous vaccination with inactivated vaccine and mRNA vaccine augments antibodies against both spike and nucleocapsid proteins of SARS-CoV-2: a local study in Macao
    Ng, Hoi Man
    Lei, Chon Lok
    Fu, Siyi
    Li, Enqin
    Leong, Sek In
    Nip, Chu Iong
    Choi, Nga Man
    Lai, Kai Seng
    Tang, Xi Jun
    Lei, Chon Leng
    Xu, Ren-He
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [34] Long-Lasting Enhanced Cytokine Responses Following SARS-CoV-2 BNT162b2 mRNA Vaccination
    Cabau, Georgiana
    Badii, Medeea
    Mirea, Andreea M.
    Gaal, Orsolya I.
    van Emst, Liesbeth
    Popp, Radu A.
    Crisan, Tania O.
    Joosten, Leo A. B.
    VACCINES, 2024, 12 (07)
  • [35] Antibody responses to inactivated and/or mRNA SARS-CoV-2 vaccination in patients with inborn errors of immunity
    Karabiber, Esra
    Atik, Ozge
    Ergan, Bilgehan
    Tepetam, Fatma Merve
    Ilki, Arzu
    Ozen, Ahmet
    Aydiner, Elif Karakoc
    Baris, Safa
    ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2024, 15 (06): : 388 - 393
  • [36] Vanishing mediastinal mass associated with mRNA SARS-CoV-2 vaccination: a rare case report
    Kosaka, Takayuki
    Nakazawa, Seshiru
    Ibe, Takashi
    Shirabe, Ken
    AME MEDICAL JOURNAL, 2022, 7
  • [37] Immunogenicity and protective efficacy of the HC009 mRNA vaccine against SARS-CoV-2
    Liu, Juan
    Han, Huafeng
    Yang, Binbin
    Zhang, Naifang
    Li, Jing
    Chen, Xicheng
    Wu, Jie
    Zhao, Yingying
    Yang, Yongsheng
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [38] Vaccination against SARS-CoV-2 in cancer patients
    von Lilienfeld-Toal, Marie
    Rieger, Christina
    Giesen, Nicola
    Woermann, Bernhard
    ONKOLOGE, 2021, 27 (07): : 691 - 696
  • [39] Engineering mRNA vaccine with broad-spectrum protection against SARS-cov-2 variants
    Du, Shuang
    Yang, Liu
    Chen, Xingguang
    Chen, Yonghao
    Weng, Liang
    Huang, Hui
    Pang, Silin
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2025, 746
  • [40] Circular mRNA Vaccine against SARS-COV-2 Variants Enabled by Degradable Lipid Nanoparticles
    Huang, Ke
    Li, Na
    Li, Yingwen
    Zhu, Jiafeng
    Fan, Qianyi
    Yang, Jiali
    Gao, Yinjia
    Liu, Yuping
    Gao, Shufeng
    Zhao, Peng
    Wei, Ke
    Deng, Chao
    Zuo, Chijian
    Sun, Zhenhua
    ACS APPLIED MATERIALS & INTERFACES, 2025, 17 (03) : 4699 - 4710
12345